Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine

Details Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine

1986-12-17

1990-12-18

Rollins, John W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514934, A61K 3170

Patent

active

049786555

ABSTRACT:
This invention relates to the use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with a retrovirus.

REFERENCES:
patent: 3322747 (1967-05-01), Shen et al.
patent: 3817982 (1974-06-01), Verheyden et al.
patent: 4360522 (1982-11-01), Shaeffer et al.
patent: 4710492 (1987-12-01), Lin et al.
Mitsuya et al., Proc. Natl. Acad. Sci. USA, 82 pp. 7096-7100 (1985).
Mitsuya et al., Proc. Natl. Acad. Sci. USA, 83 pp. 1911-1915 (1986).
Fischl et al., The New England J. of Medicine, 317 No. 4, pp. 185-191 (1987).
Herdewijn et al., J. Med. Chem., 30 pp. 1270-1278 (1987).
Lin et al., Biochemical Pharmacolog, vol. 36, No. 17, pp. 2713-2718 (1987).
Lin et al., J. Med. Chem., 30 pp. 440-444 (1987).
Kim et al., J. Med. Chem., 30 862-866 (1987).
Lin et al., Biochemical Pharmacology, 36, No. 3, 311-316 (1987).
DeClercq, J. Antimicrobial Agents and Chemotherapy 14, Suppl. A, 85-95 (1984).
De Clercq et al., Biochemical Pharmacology, 29, 1849-1851 (1980).
Machida, Antimicrobial Agents and Chemotherapy, 29, No. 3, 524-526 (1986).
De Clercq, et al., J. Med. Chem., 29 213-217 (1986).
Robins, "Synthetic Antiviral Agents", (4 EN, Jan. 27, 1986.
D. Dormant, B. Spire, F. Barre-Sinoussi, L. Montagnier and J. C. Chermann, Ann. Inst. Pasteur/Virol., 75, 136E, (1985).
W. Rosenbaum, D. Dormont, B. Spire, E. Vilmer, M. Gentilini, C. Griscelli, L. Montagnier, F. Barre-Sinoussi and J. C. Chermann, Lancet, i, 450, (1985).
D. D. Ho, K. L. Hartshorn, T. R. Rota, C. A. Andrews, J. C. Kaplan, R. T. Schoolkey and M. S. Hirsch, Lancet, i, 602 (1985).
J. B. McCormick, J. P. Getchell, S. W. Mitchell and D. R. Hicks, Lancet, ii, 1367, (1984).
E. G. Sandstrom, J. C. Kaplan, R. E. Byington and M. S. Hirsch, Lancet, i, 1480, (1984).
P. S. Sarin, Y. Taguchi, D. Sun, A. Thornton, R. C. Gallo and B. Oberg, Biochem. Pharmac., 34, 4075, (1985).
R. Anand, J. L. Moore, A. Srinivason, V. Kalyanaraman, D. Francis, P. Feorino and J. Curran, Abstracts of the International Conference on Acquired Immune Deficiency Syndrome (AIDS), Apr. 14-17, Atlanta, Ga. p. 72, (1985).
H. Mitsuya, M. Popovic, R. Yarchoan, S. Matsushita, R. C. Gallo and S. Broder, Science, 226, 172, (1984).
H. Mitsuya, S. Matsushita, M. E. Harper and S. Broder, Cancer Res., 45, 4583s, (1985).
E. DeClercq, Cancer Lett. 8, 9 (1979).
A. Pompidou, D. Zagury, R. C. Gallo, D. Sun, A. Thornton and P. S. Sarin, Lancet, ii, 1423, (1985).
P. Chandra and P. S. Sarin, Drug Res., 36 184, (1986).
R. Anand, J. Moore, P. Feorino, J. Curran and A. Srinivasan, Lancet, i, 97, (1986).
P. S. Sarin, R. C. Gallo, D. I. Scheer, F. Crews and A. S. Lippa, New Engl. J. Med., 313, 1289, (1985).
W. Ostertag, T. Cole, T. Crozier, G. Gaedicke, J. Kind, N. Kluge, J. C. Krieg, G. Roselser, G. Sheinheider, B. J. Weimann and S. K. Dube, Proceedings of the 4th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 1973, Differentiation and Control of Malignancy of Tumor Cells, Eds. W. Nakhara, T. Ono, T. Sugimura and H. Sugano, p. 485, University of Tokyo Press, Tokyo, (1974).
W. Ostertag, C. Roseler, C. J. Kreig, T. Cole, T. Crozier, G. Gaedicke, G. Steinheider, N. Kluge and S. K. Dube, Proc. Natn. Acad. Sci. USA, 71, 4980, (1974).
S. L. Dube, G. Gaedicke, N. Kluge, B. J. Weimann, H. Melderis, G. Steinheider, T. Crozier, H. Beckmann and W. Ostertag, Proceedings of the 4th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 1973, Differentiation and Control of Malignancy

Affiliated with

Also associated with

Rating

Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1425723